Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04716543
What this trial is testing

Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and Animals

Who this might be right for
Influenza -Like IllnessCovid19
ANRS, Emerging Infectious Diseases 5,400
Large-scale testing (Phase 3)UnknownNCT05602558
What this trial is testing

The Phase Ⅱ/Ⅲ Trial of LYB001

Who this might be right for
COVID-19
Yantai Patronus Biotech Co., Ltd. 18,000
Testing effectiveness (Phase 2)Ended earlyNCT04367168
What this trial is testing

Colchicine in Patients With Mild and Severe Coronavirus Disease

Who this might be right for
COVID
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 116
Not applicableUnknownNCT04821570
What this trial is testing

To Assess Immunogenicity of Coronavirus Disease 2019 (COVID-19) Vaccine in Cancer Patients Receiving Cancer Treatment

Who this might be right for
Breast CancerLung CancerMelanoma (Skin)
University of Kansas Medical Center 500
Large-scale testing (Phase 3)WithdrawnNCT04365231
What this trial is testing

Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial

Who this might be right for
COVID19
Hospital St. Joseph, Marseille, France
Not applicableStudy completedNCT05965323
What this trial is testing

Reopening Schools Safely and Educating Youth Research- Early Learning Ancillary Study

Who this might be right for
Absenteeism
University of Washington 97
Testing effectiveness (Phase 2)Study completedNCT05198102
What this trial is testing

ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic Immunization

Who this might be right for
Prevention of COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 300
Testing effectiveness (Phase 2)WithdrawnNCT06234462
What this trial is testing

Amantadine for Cognitive Dysfunction in Patients With Long-Covid

Who this might be right for
Long COVIDPost-Acute COVID-19 Syndrome
University of Texas Southwestern Medical Center
Not applicableStudy completedNCT04847596
What this trial is testing

Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 25
Not applicableStudy completedNCT04463862
What this trial is testing

COVID - AirPollution

Who this might be right for
COVID-19 Confirmed CasesCOVID-19 Mortality
University Hospital, Strasbourg, France 660
Testing effectiveness (Phase 2)Ended earlyNCT04381988
What this trial is testing

Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy

Who this might be right for
COVID-19Cancer
Memorial Sloan Kettering Cancer Center 4
Not applicableUnknownNCT04934202
What this trial is testing

Cohort Follow-up of Survivors of Hospitalization for COVID-19 During the 2nd Wave of the Epidemic in France

Who this might be right for
SequelaeFibrosisPost-COVID Syndrome+1 more
Assistance Publique - Hôpitaux de Paris 500
Not applicableUnknownNCT05755542
What this trial is testing

Long-Covid in Patients Post Rehabilitation Treatment and Reintegration Into Everyday Life

Who this might be right for
Long COVID
Rehazentrum Walenstadtberg 500
Not applicableStudy completedNCT04379154
What this trial is testing

Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19)

Who this might be right for
COVID-19
Hopital Foch 65
Not applicableStudy completedNCT05464680
What this trial is testing

Pulmonary Diffusion of Antibiotics in Patients Admitted for ARDS Following SARS-CoV-2 Pneumonia

Who this might be right for
ARDSSARS-CoV 2 Pneumonia
Assistance Publique Hopitaux De Marseille 34
Not applicableStudy completedNCT05384886
What this trial is testing

Impact of New Variants and Vaccines on the Course of COVID-19

Who this might be right for
COVID-19
Izmir Katip Celebi University 15,967
Testing effectiveness (Phase 2)Study completedNCT04399356
What this trial is testing

Niclosamide for Mild to Moderate COVID-19

Who this might be right for
COVID-19
Tufts Medical Center 73
Not applicableStudy completedNCT04590222
What this trial is testing

Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19

Who this might be right for
SARS-CoV2 Infection
Assistance Publique - Hôpitaux de Paris 51
Large-scale testing (Phase 3)Not Yet RecruitingNCT06907251
What this trial is testing

Dapagliflozin for Long COVID Syndrome

Who this might be right for
COVID - 19Long COVID SyndromeSARS CoV-2
Ottawa Heart Institute Research Corporation 192
Testing effectiveness (Phase 2)Study completedNCT04313023
What this trial is testing

The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2

Who this might be right for
COVID-19
Pulmotect, Inc. 217
Next Page